मैगज़्टर गोल्ड के साथ असीमित हो जाओ

मैगज़्टर गोल्ड के साथ असीमित हो जाओ

9,500 से अधिक पत्रिकाओं, समाचार पत्रों और प्रीमियम कहानियों तक असीमित पहुंच प्राप्त करें सिर्फ

$149.99
 
$74.99/वर्ष

कोशिश गोल्ड - मुक्त

Maharashtra, powerhouse of Indian pharma industry

Chronicle Pharmabiz

|

September 18, 2025

MAHARASHTRA, particularly the Mumbai-Pune corridor, is indisputably the powerhouse of the Indian pharmaceutical industry.

- Namdeo Shinde

Contributing approximately 25-30 per cent of India's total pharmaceutical output and housing over 40 per cent of the nation's pharmaceutical R&D centres, the state is a critical hub for manufacturing, innovation, and exports. However, this preeminent position is challenged by intense domestic competition, infrastructural bottlenecks, environmental concerns, and a rapidly evolving global regulatory landscape.

Region-wise distribution of pharma industry

The pharmaceutical industry in Maharashtra is strategically concentrated in key regional clusters, each with a distinct role. The Mumbai Metropolitan Region (MMR), encompassing Mumbai, Thane, Navi Mumbai, and Palghar, remains the historical and corporate heartland.

It hosts the headquarters of industry giants like Cipla, Sun Pharma, and multinational corporations such as Pfizer and GSK, serving as a central hub for corporate functions, regulatory affairs, marketing, and R&D. While still a dominant centre for formulating complex drugs and vaccines, its high operational costs and space constraints are gradually shifting manufacturing focus to other regions.

According to the Maharashtra Industrial Development Corporation (MIDC), the Mumbai and Konkan region continues to account for a significant, though dynamically changing, portion of the state's pharmaceutical units.

In contrast, Pune has solidified its status as the emerging "Pharma & Biotech Capital" of India. The region, including Pune city, Pimpri-Chinchwad, and Hinjawadi, is an epicentre of innovation, hosting a dense cluster of R&D centres, CRAMS players, and biotech startups, bolstered by world-class institutions like the National Chemical Laboratory and the Serum Institute of India. A report by the India Brand Equity Foundation (IBEF) highlights its prominence, noting over 800 manufacturing units in the broader region.

Chronicle Pharmabiz से और कहानियाँ

Chronicle Pharmabiz

Chromatography: Detecting volatile organic compounds

CHROMATOGRAPHY is a method or analytical process for separating mixtures based on differences in the speed at which they migrate over or through a stationary phase. This process can separate complex mixtures of chemicals or proteins into their various different components.

time to read

4 mins

September 18, 2025

Chronicle Pharmabiz

Bulk drugs, intermediates imports grow 5 per cent

IMPORTS of bulk drugs and intermediates to India registered a growth of 5% in the month of July, 2025, while the cumulative imports for the first four months of the fiscal year witnessed a decline of 3.8%.

time to read

2 mins

September 18, 2025

Chronicle Pharmabiz

Chronicle Pharmabiz

Gandhi Automations offers PRIME NEO for clean environment

GANDHI Automations Pvt Ltd, India's number one entrance automation and loading bay equipment company, offers multi-composites and highperformance door, PRIME NEO for clean environments.

time to read

1 mins

September 18, 2025

Chronicle Pharmabiz

Healthcare shifts to patient-centric infra

THE healthcare sector in the country is undergoing a transformative shift, placing patients and sustainability at the heart of its infrastructure development. Hospitals and medical facilities across the country are increasingly adopting designs that prioritize patient comfort, healing environments, and eco-friendly operations.

time to read

2 mins

September 18, 2025

Chronicle Pharmabiz

Tech to enhance various aspects of healthcare: Experts

INDIAN digital technology is placing engineers as the pivot of healthcare innovation and recognizing them as the fulcrum for transforming the future of medical care. Their expertise is crucial in integrating technology with healthcare systems, ensuring efficient, personalized, and scalable solutions that meet the evolving needs of the population.

time to read

1 mins

September 18, 2025

Chronicle Pharmabiz

KPRDO opposes Abbott's move restricting distribution of Freestyle Libre

THE Karnataka Pharma Retailers & Distributors Organization (KPRDO) has reported a sharp increase in patient enquiries and concerns over the availability of Freestyle Libre sensors, following Abbott's recent decision to restrict distribution of the popular glucose monitoring device exclusively to online platforms.

time to read

2 mins

September 18, 2025

Chronicle Pharmabiz

KEA to handle D Pharm seat allotment for govt, private quotas

KARNATAKA government has decided that seat allotment for D Pharmacy (D Pharm) courses from the academic year 2025-26 for both the government and private quota seats will be handled through the Karnataka Examinations Authority (KEA).

time to read

2 mins

September 18, 2025

Chronicle Pharmabiz

CRC Press releases book on Ashwagandha

CRC Press, Taylor and Francis Group have released a dedicated book on Ashwagandha: Potential Drug Candidate from Ancient Ayurvedic Remedy. The editors are Dilip Ghosh and Benny Antony.

time to read

1 mins

September 18, 2025

Chronicle Pharmabiz

Indian life sciences charts a pathway for AI-driven regulatory submissions

INDIAN life sciences sector is charting a transformative growth story, one that will position the country as a leader in Al-driven regulatory submissions and data standardization.

time to read

2 mins

September 18, 2025

Chronicle Pharmabiz

'GST restructuring as a game-changing step'

THE Federation of Pharmaceutical Entrepreneurs (FOPE), Karnataka Drugs and Pharmaceutical Manufacturers Association (KDPMA), consultancy majors Grant Thornton Bharat and EY have underscored that the Union govť's move on GST restructuring is a game-changing step.

time to read

1 min

September 18, 2025

Listen

Translate

Share

-
+

Change font size